Reneo Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Reneo Pharmaceuticals generated cash of -$63,682,000, which is less than the previous year. Cash used in financing activities reached the amount of $60,865,000 last year. Net change in cash is therefore $7,705,000.
Cash Flow
| 2019 | -12.51M | -7.24M | 24.98M |
|---|---|---|---|
| 2020 | -18.53M | 7.37M | 47.27M |
| 2021 | -37.98M | -23.37M | 132.40M |
| 2022 | -47.36M | -57.84M | 471K |
| 2023 | -63.68M | 10.52M | 60.86M |
RPHM Cash Flow Statement (2019 – 2023)
| 2023 | 2022 | 2021 | 2020 | 2019 | |
|---|---|---|---|---|---|
Cash at beginning of period | 19.92M | 124.66M | 53.61M | 17.50M | 12.26M |
Operating activities | |||||
Net income | -77.38M | -51.95M | -39.77M | -19.46M | -12.43M |
| Adjustments to reconcile net income to cash generated by operating activities: | |||||
Depreciation and amortization | 525K | 88K | 50K | 37K | 34K |
Stock-based compensation expense | 5.11K | 4.32K | 3.89M | 393K | 388 |
| Deferred income tax benefit | 5.11K | 4.32K | 3.89M | 393K | 388 |
| Changes in operating assets and liabilities: | |||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 |
Accounts payable | 11.11M | 518K | 1.78M | 1.48M | 1.03M |
Cash generated by operating activities | -63.68M | -47.36M | -37.98M | -18.53M | -12.51M |
Investing activities | |||||
Purchases Of Investments | -231.25M | -101.59M | -31.40M | 0 | -19.83M |
Investments In Property Plant And Equipment | -221K | -346K | -198K | -24K | -7K |
Acquisitions Net | 0 | 57.49K | 23.17K | 0 | 7.23K |
Cash generated by investing activities | 10.52M | -57.84M | -23.37M | 7.37M | -7.24M |
Financing activities | |||||
Common Stock Issued | 64.53M | 193K | 132.40M | 47.27M | 24.98M |
Payments for dividends | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | -4.40M | 0 | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | 0 |
Cash used in financing activities | 60.86M | 471K | 132.40M | 47.27M | 24.98M |
Net Change In Cash | 7.70M | -104.73M | 71.04M | 36.11M | 5.23M |
Cash at end of period | 27.63M | 19.92M | 124.66M | 53.61M | 17.50M |
| Data source | Data source | Data source |